Browsing Over 990 Presentations
Sort By
Navigating the waters of ES-SCLC (ID 1781)
Q&A (ID 1787)
Presentation of real world outcomes in ER+ HER2- mBC (ID 1792)
Generating meaningful evidence with novel trial designs and real-world data (ID 1797)
ESMO Colloquium supported by Lilly Oncology: Biomarker-driven treatment decision in metastatic NSCLC
ESMO Colloquium
Conclusion
Lecture Time
02:05 PM - 02:10 PM
Session Name
Location
Hall 407, Singapore, Singapore, Singapore
Date
Fri, 22.11.2019
Time
12:45 PM - 02:15 PM
The landscape and role of IO-Chemo combination in NSCLC treatment (ID 1802)
Introduction (ID 1779)
PARPi maintenance: A new paradigm in the management of frontline ovarian cancer (ID 1784)
From clinical trials to practice: Changing the trajectory for metastatic breast cancer patients (ID 1790)
Introduction (ID 1795)
ESMO Colloquium supported by Lilly Oncology: Biomarker-driven treatment decision in metastatic NSCLC
ESMO Colloquium
Future development for the use of biomarkers
Lecture Time
01:40 PM - 02:05 PM
Session Name
Speakers
- Ross A. Soo
Location
Hall 407, Singapore, Singapore, Singapore
Date
Fri, 22.11.2019
Time
12:45 PM - 02:15 PM
Authors
- Ross A. Soo